The Cutaneous Connection: Episode 30- Impact of the JAK Inhibitor Approval Delays
September 2nd 2021Mark Lebwohl, MD, takes a deep dive in the recent delay in approval for multiple JAK inhibitor drugs for treatment of inflammatory skin conditions such as psoriasis and atopic dermatitis. He also discusses the impact of the delay, as well as the benefits of JAK inhibitors for inflammatory skin diseases, and an outlook for the future of this drug class.
The Cutaneous Connection: Episode 29- Do Diet and Supplements Affect Psoriasis?
August 19th 2021In this episode, Jennifer Powers, MD, board certified dermatologist and associate professor of dermatology at the University of Iowa, discusses her recent research exploring how diet and supplements affect patients with mild psoriasis.
FDA Clears ellacor Micro-Coring Technology for Wrinkles
August 11th 2021Roy Geronemus, MD, clinical professor of dermatology at New York University Medical Center & Dermatology Times editorial advisory board member, discusses the recent FDA clearance of ellacor Micro-Coring Technology for treatment of moderate to severe wrinkles in the mid to lower face.
The Cutaneous Connection: Episode 28- The Path to Understanding Pediatric Melanoma
August 5th 2021In this episode, Alberto Pappo, MD, director, St. Jude Solid Tumor Division, discusses a registry he helped create aimed at helping physicians better understand pediatric melanoma called Molecular Analysis of Childhood MELanocytic Tumors (MACMEL).